Max Robotics — Global Service Robot Directory + US Certification

About

Wasay Nizam is a pioneering researcher in non-invasive liquid biopsy diagnostics, with a primary focus on leveraging small non-coding RNAs (sncRNAs) for early cancer detection. His most cited work introduces a cost-effective, non-invasive test based on plasma protein functional effector sncRNAs (pfeRNAs) that successfully differentiates benign, suspicious, and malignant pulmonary nodules. This breakthrough addresses a critical clinical challenge—avoiding unnecessary invasive procedures for benign nodules while enabling timely intervention for early-stage lung cancers. With 9 citations to date, this study has already influenced the field of oncological biomarker discovery. Nizam’s contributions are notable for bridging molecular biology and clinical utility, offering a scalable solution for lung cancer screening. His research underscores the potential of pfeRNAs as robust, accessible diagnostic tools, positioning him as an emerging leader in precision oncology and non-invasive diagnostics.